Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP
NCT05215561
·
clinicaltrials.gov ↗
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis Vulgaris
Psoriatic Arthritis
Pustular Psoriasis
Interventions
OTHER:
Cosentyx
Sponsor
Novartis Pharmaceuticals